Enalapril Prevents Tubulointerstitial Lesions by Hyperoxaluria

作者: Jorge Eduardo Toblli , Inés Stella , Elena de Cavanagh , Margarita Angerosa , Felipe Inserra

DOI: 10.1161/01.HYP.33.1.225

关键词:

摘要: Hyperoxaluria is a recognized cause of tubulointerstitial lesions, and this could contribute to development hypertension chronic renal failure. Enalapril has been effective against the progression lesions in various animal models. The aim present study was evaluate usefulness enalapril on damage produced by oxalates. Two-month-old male Sprague-Dawley rats were separated into 4 groups, control with tap water (G1), hyperoxaluric (G2), hyperoxaluric+enalapril (G3), (G4), for weeks. G2 G3 given 1% ethyleneglycol (ETG, precursor oxalates), G4 20 mg/L drinking water. At end study, we evaluated semiquantitative score. Urine albumin excretion, serum urine nitric oxide production, immunostaining alpha-smooth muscle actin, transforming growth factor-beta1, collagen type III measured. Rats belonging group treated (G3) showed fewer (1.3+/-0.2 versus 3+/-0.2; P<0.01), lower excretion (8+/-2 mg/d 25+/-2 mg/d; less percentage actin interstitium (2+/-0.4% 13.5+/-2.4%; factor-beta1 area (3.3+/-1% 13.3+/-2. 1%; interstitial deposition (0.7+/-0.5% 7+/-2.6%; increased NO production as well (both when compared not (G2). Considering these data, believe that enalapril, several mechanisms action, provide an important benefit prevention inflammatory response, deposition, finally, progressive fibrosis caused

参考文章(25)
P Gohlke, T Unger, G Wiemer, B A Schölkens, W Linz, Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacological Reviews. ,vol. 47, pp. 25- 49 ,(1995)
S Klahr, R McCracken, J J Morrissey, S Ishidoya, Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy. Journal of The American Society of Nephrology. ,vol. 7, pp. 2202- 2212 ,(1996) , 10.1681/ASN.V7102202
E. A. Burdmann, T. F. Andoh, C. C. Nast, A. Evan, B. A. Connors, T. M. Coffman, J. Lindsley, W. M. Bennett, Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril American Journal of Physiology-renal Physiology. ,vol. 269, ,(1995) , 10.1152/AJPRENAL.1995.269.4.F491
E. M. de Cavanagh, C. G. Fraga, L. Ferder, F. Inserra, Enalapril and captopril enhance antioxidant defenses in mouse tissues American Journal of Physiology-regulatory Integrative and Comparative Physiology. ,vol. 272, ,(1997) , 10.1152/AJPREGU.1997.272.2.R514
L. Ercole, L. A. Romano, F. Inserra, R. A. Gomez, L. F. Ferder, E. M. V. De Cavanagh, Renal interstitial sclerosis in aging: effects of enalapril and nifedipine. Journal of The American Society of Nephrology. ,vol. 7, pp. 676- 680 ,(1996) , 10.1681/ASN.V75676
M Weber, S L Goodman, R B Sterzel, E Schulze-Lohoff, Interactions between glomerular mesangial cells, cytokines, and extracellular matrix. Journal of The American Society of Nephrology. ,vol. 2, ,(1992) , 10.1681/ASN.V210S126
Barry M. Brenner, C. Craig Tisher, Renal Pathology With Clinical and Functional Correlations ,(1994)
Nancy A. Noble, Wayne A. Border, Angiotensin II in renal fibrosis: should TGF-beta rather than blood pressure be the therapeutic target? Seminars in Nephrology. ,vol. 17, pp. 455- 466 ,(1997)